Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
CCND1 overexpression
i
Other names:
CCND1, BCL1, D11S287E, PRAD1, U21B31, Cyclin D1
Associations
(8)
News
Trials
C2 | Sensitive
C3 | Sensitive
D | Sensitive
C2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
PI3 Kinase Inhibitors
Tyrosine Kinase Inhibitors
PARP Inhibitors
Proteasome Inhibitors
Hormone Therapy
Serine-Threonine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
CD Protein Inhibitors
Cancel
Multiple Myeloma
Mantle Cell Lymphoma
Breast Cancer
Estrogen Receptor Positive Breast Cancer
Squamous Cell Skin Cancer
Ependymoma
bortezomib
C3
CCND1 overexpression
|
Multiple Myeloma
|
bortezomib
INCB50465
C2
CCND1 overexpression
|
Mantle Cell Lymphoma
|
INCB50465
ABT-888
C3
CCND1 overexpression
|
Breast Cancer
|
ABT-888
tamoxifen
C3
CCND1 overexpression
|
Estrogen Receptor Positive Breast Cancer
|
tamoxifen
everolimus
C3
CCND1 overexpression
|
Squamous Cell Skin Cancer
|
everolimus
abemaciclib
D
CCND1 overexpression
|
Ependymoma
|
abemaciclib
palbociclib
D
CCND1 overexpression
|
Breast Cancer
|
palbociclib
AMG 386
C3
CCND1 overexpression
|
Breast Cancer
|
AMG 386
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
